Axonics Modulation Technologies (NSDQ:AXNX) shares rose today on fourth-quarter results that beat the consensus forecast on Wall Street. The Irvine, California-based sacral neuromodulation (SNM) technology developer posted losses of $15.2 million, or 34¢ per share, on sales of $53.1 million for the three months ended Dec. 31, 2021, for a bottom-line of nearly $4 million […]
Implants
LivaNova implants first patient in Osprey obstructive sleep apnea study
LivaNova (NSDQ:LIVN) announced that it completed the first patient implant in a study of its LivaNova aura6000 system. London-based LivaNova designed the aura6000 system to maintain muscle tone of the tongue and upper airway so that airway obstruction and resulting sleep apnea are significantly reduced or eliminated. The hypoglossal neurostimulator system includes a programmable, rechargeable […]
Nevro rises on Street-beating Q4 sales
Nevro (NYSE:NVRO) shares ticked up today on fourth-quarter results that beat the consensus revenue forecast. The Redwood City, California-based company posted losses of $30.1 million, or -86¢ per share, on sales of $102.8 million for the three months ended Dec. 31, 2021, for a large bottom-line slide deeper into the red on a sales decline […]
Glaukos rises on Street-beating Q4
Glaukos (NYSE:GKOS) shares ticked up today on fourth-quarter results that beat the consensus forecast. The San Clemente, California-based eye disease treatment developer posted losses of $21.9 million, or losses per share of 47¢, on sales of $73.2 million for the three months ended Dec. 31, 2021, for a bottom-line slide deeper into the red on […]
FDA approves Medtronic’s next-gen InterStim X system
Medtronic (NYSE:MDT) announced today that the FDA approved its next-generation InterStim X recharge-free device. The medtech giant has made the latest sacral neuromodulation (SNM) therapy product from the InterStim portfolio available immediately. The recharge-free InterStim X and the rechargeable InterStim Micro are both used to treat overactive bladder (OAB), chronic fecal incontinence (FI) and non-obstructive […]
Smith+Nephew rises on Q4 earnings, announces new CEO
Smith+Nephew (NYSE:SNN) shares ticked up today as it announced a new CEO along with its quarterly earnings. Shares of SNN were up 6.4% at $34.67 per share in late-afternoon trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — was up 1%. The company confirmed that Deepak […]
What happens when bionic eye implants suddenly go dark?
An update on the Second Sight Medical Products (NASDAQ:EYES) saga comes to us by way of IEEE Spectrum, offering a cautionary tale for the developers of cutting-edge implants and the patients who place their faith in them. The future remains cloudy for the Los Angeles–based developer of the Argus 2s retinal prosthesis system, which is […]
Microsoft CMO: Using the cloud to improve medtech design, manufacturing and care
Dr. David Rhew, Microsoft’s global chief medical officer and VP of healthcare, has been studying how technology can improve health outcomes for nearly three decades. His focus has long been on access to care, quality of care, patient safety, improving experiences for patients and providers, and finding ways to improve the overall efficiency of care. […]
CVRx misses in Q4, wins FDA approval for new IPG
CVRx (NSDQ:CVRX) posted fourth-quarter results today that fell short of the consensus forecast on Wall Street and offered its outlook for the year ahead. The Brooklyn Park, Minnesota–based neuromodulation implant developer reported a loss of $10.57 million, or $0.52 per diluted share, on sales of $3.7 million for the three months ended Dec. 31, 2021, […]
Companion Spine raises $55M Series A
Diagnostic and interventional spine surgery company Companion Spine announced today that it raised $55 million in a Series A financing. Companion Spine, which has headquarters in New York and Bordeaux, France, had its financing led by Viscogliosi Brothers, the company’s co-founder and historical shareholder, and jointly invested by a leading global medtech company. Viscogliosi Brothers […]
Experiments by Elon Musk’s Neuralink and UC Davis allegedly caused extreme suffering in monkeys
Elon Musk’s brain implant startup, Neuralink, and the University of California, Davis, have been accused of “egregious violations of the Animal Welfare Act” by the Physicians Committee for Responsible Medicine (PCRM), citing documents obtained through a public records lawsuit. The nonprofit — which successfully pressured U.S. medical schools including Johns Hopkins to stop using live […]